The present invention relates to it is a kind of treat GD2 positive cancers comprising by application preparation anti-GD2 antibody to patient, wherein the dosage of the preparation administration is enough to induce tumor cell lysis (cell dissolution threshold dose), wherein cell dissolution threshold dose administration is until make a reservation for total patient dose application.